Literature DB >> 31964186

High-intensity interval training is effective and superior to moderate continuous training in patients with heart failure with preserved ejection fraction: A randomized clinical trial.

Anderson Donelli da Silveira1,2,3,4, Juliana Beust de Lima2,3, Diogo da Silva Piardi3, Débora Dos Santos Macedo2, Maurice Zanini2, Rosane Nery2,3, Jari A Laukkanen5,6, Ricardo Stein2,3,4,7.   

Abstract

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a prevalent syndrome, with exercise intolerance being one of its hallmarks, contributing to worse quality of life and mortality. High-intensity interval training is an emerging training option, but its efficacy in HFpEF patients is still unknown.
DESIGN: Single-blinded randomized clinical trial.
METHODS: Single-blinded randomized clinical trial with exercise training 3 days per week for 12 weeks. HFpEF patients were randomly assigned to high-intensity interval training or moderate continuous training. At baseline and after 12 week follow-up, patients underwent clinical assessment, echocardiography and cardiopulmonary exercise testing (CPET).
RESULTS: Mean age was 60 ± 9 years and 63% were women. Both groups (N = 19) showed improved peak oxygen consumption (VO2), but high-intensity interval training patients (n = 10) had a significantly higher increase, of 22%, compared with 11% in the moderate continuous training (n = 9) individuals (3.5 (3.1 to 4.0) vs. 1.9 (1.2 to 2.5) mL·kg-1·min-1, p < 0.001). Ventilatory efficiency and other CPET measures, as well as quality of life score, increased equally in the two groups. Left ventricular diastolic function also improved with training, reflected by a significant reduction in E/e' ratio by echocardiography (-2.6 (-4.3 to -1.0) vs. -2.2 (-3.6 to -0.9) for high-intensity interval training and moderate continuous training, respectively; p < 0.01). There were no exercise-related adverse events.
CONCLUSIONS: This randomized clinical trial provided evidence that high-intensity interval training is a potential exercise modality for HFpEF patients, being more effective than moderate continuous training in improving peak VO2. However, the two strategies were equally effective in improving ventilatory efficiency and other CPET parameters, quality of life score and diastolic function after 3 months of training.

Entities:  

Keywords:  Exercise training; heart failure; peak oxygen uptake

Year:  2020        PMID: 31964186     DOI: 10.1177/2047487319901206

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  10 in total

1.  Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Authors:  Stephan Mueller; Ephraim B Winzer; André Duvinage; Andreas B Gevaert; Frank Edelmann; Bernhard Haller; Elisabeth Pieske-Kraigher; Paul Beckers; Anna Bobenko; Jennifer Hommel; Caroline M Van de Heyning; Katrin Esefeld; Pia von Korn; Jeffrey W Christle; Mark J Haykowsky; Axel Linke; Ulrik Wisløff; Volker Adams; Burkert Pieske; Emeline M van Craenenbroeck; Martin Halle
Journal:  JAMA       Date:  2021-02-09       Impact factor: 56.272

Review 2.  The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review.

Authors:  Eglė Palevičiūtė; Toma Šimbelytė; Christina A Eichstaedt; Nicola Benjamin; Benjamin Egenlauf; Ekkehard Grünig; Jelena Čelutkienė
Journal:  Heart Fail Rev       Date:  2022-07-13       Impact factor: 4.654

3.  Effects of high-intensity interval training in patients with coronary artery disease after percutaneous coronary intervention: A systematic review and meta-analysis.

Authors:  Xinyue Zhang; Dongmei Xu; Guozhen Sun; Zhixin Jiang; Jinping Tian; Qijun Shan
Journal:  Nurs Open       Date:  2021-02-02

4.  Effects of High-Intensity Interval vs. Moderate-Intensity Continuous Training on Cardiac Rehabilitation in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Tian Yue; Yan Wang; Hui Liu; Zhaowei Kong; Fengxue Qi
Journal:  Front Cardiovasc Med       Date:  2022-02-23

5.  Physical Exercise Modalities for the Management of Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.

Authors:  Yuan Guo; Changhu Xiao; Kaixuan Zhao; Ziyu He; Sha Liu; Xuemei Wu; Shuting Shi; Zhu Chen; Ruizheng Shi
Journal:  J Cardiovasc Pharmacol       Date:  2022-05-01       Impact factor: 3.271

6.  Systematic Review and Meta-Analysis on the Rehabilitation Effect of Different Intensity Exercise on the Patients with Cardiovascular Diseases.

Authors:  Tao Yu; Zhi Zhang; Donglai Zhou; Cairong Li
Journal:  Comput Math Methods Med       Date:  2022-07-30       Impact factor: 2.809

Review 7.  Effects of Exercise on Heart Failure with Preserved Ejection Fraction: An Updated Review of Literature.

Authors:  Giulia Crisci; Mariarosaria De Luca; Roberta D'Assante; Brigida Ranieri; Anna D'Agostino; Valeria Valente; Federica Giardino; Valentina Capone; Salvatore Chianese; Salvatore Rega; Rosangela Cocchia; Muhammad Zubair Israr; Radek Debiek; Liam M Heaney; Andrea Salzano
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28

Review 8.  The Effects of Interval Training and Continuous Training on Cardiopulmonary Fitness and Exercise Tolerance of Patients with Heart Failure-A Systematic Review and Meta-Analysis.

Authors:  Daxin Li; Ping Chen; Junying Zhu
Journal:  Int J Environ Res Public Health       Date:  2021-06-23       Impact factor: 3.390

Review 9.  Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Authors:  Eng Leng Saw; Swetha Ramachandran; Maria Valero-Muñoz; Flora Sam
Journal:  Curr Opin Cardiol       Date:  2021-03-01       Impact factor: 2.108

Review 10.  Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction.

Authors:  Danielle L Kirkman; Natalie Bohmke; Hayley E Billingsley; Salvatore Carbone
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.